Clinical trial · Interventional
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers
Genetic Testing for Breast, Ovarian, Pancreatic, and Prostate Cancers - GeneBOPP
NCT04330716CI-TRIAL-00073126GeneBOPPcompletedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study is evaluating the effect of two pre-test education methods on participants interested in genetic testing for hereditary cancer risk.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Metastatic Prostate Cancer | Malignant Prostate Neoplasm | CURATED_BROADER | 0.78 |
| Ovarian Cancer | Malignant Ovarian Neoplasm | CURATED_EXACT | 0.92 |
| Pancreatic Cancer | Malignant Pancreatic Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Educational Video | Behavioral | — | UNRESOLVED |
| Standard Genetic Counseling | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- ACTIVE_COMPARATOR
- label
- Group A: Standard genetic counseling
- description
- Will receive standard genetic counseling prior to genetic testing.
- interventionNames
- Behavioral: Standard Genetic Counseling
- type
- EXPERIMENTAL
- label
- Group B: Educational video
- description
- Will watch a brief educational video that is approximately 8 minutes in length about the genetic testing process and what to expect prior to genetic testing.
- interventionNames
- Behavioral: Educational Video
Primary outcomes (1)
- measure
- Rate of patients who have germline genetic tests
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Potentially eligible participants will be identified via medical record screening and/or in accordance with their clinical visit. A HIPAA waiver of authorization will be obtained by the enrolling Institution as needed to have access to the subject's medical record information for screening of eligibility. * A member of the study team will approach the potentially eligible participant in clinic and discuss the trial. Potentially eligible participants may choose to discuss participation further with their physician at their appointment * Age ≥ 18 years * Breast, ovarian, pancreatic, or metastatic prostate cancer * No prior cancer genetic testing * Ability to understand and the willingness to sign an informed consent document Exclusion Criteria: * Pregnant * Prisoners * Inability to understand English as a spoken language in a healthcare context * Known hematologic malignancy (e.g. CLL)
References
Publications (0)
Data not yet available
No reference posted for this study.